ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(17)33297-x
◽
2018
◽
Vol 391
(10122)
◽
pp. 748-757
◽
Cited By ~ 465
Author(s):
Thomas Powles
◽
Ignacio Durán
◽
Michiel S van der Heijden
◽
Yohann Loriot
◽
Nicholas J Vogelzang
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Urothelial Carcinoma
◽
Controlled Trial
◽
Locally Advanced
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Metastatic Urothelial Carcinoma
◽
Randomised Controlled
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.732342155.793578099
◽
2020
◽
Author(s):
Matthew Milowsky
Keyword(s):
Randomised Controlled Trial
◽
Urothelial Carcinoma
◽
Controlled Trial
◽
Locally Advanced
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Metastatic Urothelial Carcinoma
◽
Randomised Controlled
Download Full-text
Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO
SSRN Electronic Journal
◽
10.2139/ssrn.3478102
◽
2019
◽
Author(s):
Chiara Cremolini
◽
Carlotta Antoniotti
◽
Daniele Rossini
◽
Sara Lonardi
◽
Fotios Loupakis
◽
...
Keyword(s):
Colorectal Cancer
◽
Randomised Controlled Trial
◽
Metastatic Colorectal Cancer
◽
Controlled Trial
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(19)30723-8
◽
2019
◽
Vol 393
(10189)
◽
pp. 2404-2415
◽
Cited By ~ 233
Author(s):
Brian I Rini
◽
Thomas Powles
◽
Michael B Atkins
◽
Bernard Escudier
◽
David F McDermott
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Randomised Controlled Trial
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Controlled Trial
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial
European Urology
◽
10.1016/j.eururo.2020.04.021
◽
2020
◽
Vol 78
(4)
◽
pp. 630-631
Author(s):
Teele Kuusk
◽
Axel Bex
Keyword(s):
Adjuvant Chemotherapy
◽
Randomised Controlled Trial
◽
Urothelial Carcinoma
◽
Controlled Trial
◽
Upper Tract Urothelial Carcinoma
◽
Open Label
◽
Phase 3
◽
Upper Tract
◽
Randomised Controlled
Download Full-text
Re: Alison Birtle, Mark Johnson, John Chester, et al. Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. Lancet 2020;395:1268–77
European Urology
◽
10.1016/j.eururo.2020.09.013
◽
2021
◽
Vol 79
(1)
◽
pp. e28
Author(s):
Nirmish Singla
◽
Vitaly Margulis
Keyword(s):
Adjuvant Chemotherapy
◽
Randomised Controlled Trial
◽
Urothelial Carcinoma
◽
Controlled Trial
◽
Upper Tract Urothelial Carcinoma
◽
Open Label
◽
Phase 3
◽
Upper Tract
◽
Mark Johnson
◽
Randomised Controlled
Download Full-text
Safety and effectiveness of intravenous iron sucrose versus standard oral iron therapy in pregnant women with moderate-to-severe anaemia in India: a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Global Health
◽
10.1016/s2214-109x(19)30427-9
◽
2019
◽
Vol 7
(12)
◽
pp. e1706-e1716
◽
Cited By ~ 6
Author(s):
Sutapa B Neogi
◽
Niveditha Devasenapathy
◽
Ranjana Singh
◽
Himanshu Bhushan
◽
Duru Shah
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Pregnant Women
◽
Controlled Trial
◽
Intravenous Iron
◽
Severe Anaemia
◽
Iron Sucrose
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Faculty Opinions recommendation of Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717950273.793455532
◽
2012
◽
Author(s):
Alexander Eggermont
Keyword(s):
Randomised Controlled Trial
◽
Metastatic Melanoma
◽
Controlled Trial
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
The Lancet Oncology
◽
10.1016/s1470-2045(20)30452-6
◽
2020
◽
Vol 21
(10)
◽
pp. 1317-1330
◽
Cited By ~ 3
Author(s):
Shaji K Kumar
◽
Susanna J Jacobus
◽
Adam D Cohen
◽
Matthias Weiss
◽
Natalie Callander
◽
...
Keyword(s):
Multiple Myeloma
◽
Stem Cell
◽
Randomised Controlled Trial
◽
Stem Cell Transplantation
◽
Controlled Trial
◽
Newly Diagnosed
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
The Lancet Oncology
◽
10.1016/s1470-2045(13)70549-7
◽
2014
◽
Vol 15
(1)
◽
pp. 78-86
◽
Cited By ~ 290
Author(s):
Hugo E R Ford
◽
Andrea Marshall
◽
John A Bridgewater
◽
Tobias Janowitz
◽
Fareeda Y Coxon
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Controlled Trial
◽
Symptom Control
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
The Lancet
◽
10.1016/s0140-6736(12)60868-x
◽
2012
◽
Vol 380
(9839)
◽
pp. 358-365
◽
Cited By ~ 1908
Author(s):
Axel Hauschild
◽
Jean-Jacques Grob
◽
Lev V Demidov
◽
Thomas Jouary
◽
Ralf Gutzmer
◽
...
Keyword(s):
Randomised Controlled Trial
◽
Metastatic Melanoma
◽
Controlled Trial
◽
Open Label
◽
Phase 3
◽
Open Label Phase
◽
Randomised Controlled
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close